C
Concord Biotech
CONCORDBIO Share Price
Healthcare1,182.20
as on 13 Mar 2026 at 15:46
Market Cap
₹12,368 Cr
PE Ratio
39.50
ROCE
26.76%
CONCORDBIO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
12,368
PE Ratio
39.50
PB Ratio
6.72
Dividend Yield
0.75%
ROE
20.50%
ROCE
26.76%
Book Value (₹)
174.68
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 44.08% | 44.08% | 44.08% | 44.08% | 44.08% |
| Domestic Institutional Investors (DII) | 9.66% | 9.16% | 8.87% | 9.55% | 9.58% |
| Foreign Institutional Investors (FII) | 8.33% | 9.35% | 9.11% | 8.03% | 7.58% |
| Public Investors | 7.33% | 6.94% | 7.43% | 7.77% | 8.11% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
CONCORDBIO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Smallcap
BSE Scrip Code
543960
NSE Scrip Name
CONCORDBIO
ISIN
INE338H01029



